Federated Hermes, Inc. Co Diagnostics, Inc. Transaction History

Federated Hermes, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.04 - $1.64 $2,840 - $4,478	2,731 New	2,731 $3,000
Q2 2022 Aug 15, 2022	SELL	$3.76 - $6.29 $2,827 - $4,730	-752 Reduced 1.51%	48,932 $275,000
Q1 2022 May 13, 2022	SELL	$5.03 - $9.61 $7,494 - $14,318	-1,490 Reduced 2.91%	49,684 $307,000
Q4 2021 Feb 14, 2022	SELL	$8.12 - $10.37 $159,436 - $203,614	-19,635 Reduced 27.73%	51,174 $457,000
Q3 2021 Nov 15, 2021	SELL	$7.48 - $11.38 $88,832 - $135,148	-11,876 Reduced 14.36%	70,809 $689,000
Q2 2021 Aug 16, 2021	BUY	$7.16 - $9.56 $592,024 - $790,468	82,685 New	82,685 $682,000
Q1 2021 May 13, 2021	SELL	$8.52 - $19.21 $13,069 - $29,468	-1,534 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$9.3 - $15.19 $3,720 - $6,076	400 Added 35.27%	1,534 $14,000
Q3 2020 Nov 12, 2020	BUY	$8.24 - $30.8 $9,344 - $34,927	1,134 New	1,134 $15,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $28M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.